Search research articles
Contact Us
Filters
Showing results (61-70 of 115) with videos related to
Page
of 12
Sort By:
Oncogene
|
September 7, 1995
Telomerase activity in normal and malignant murine tissues
C Chadeneau, P Siegel, C B Harley, et al.
International Journal of Oncology
|
April 18, 1998
Tumour therapy in mice using adenovirus vectors expressing human TNFa
R A Marr, M Hitt, W J Muller, et al.
Molecular and Cellular Biology
|
September 1, 1997
Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation
D L Dankort, Z Wang, V Blackmore, et al.
Gene Therapy
|
June 25, 2002
Intratumoral administration of an adenovirus expressing a kinase dead form of ErbB-2 inhibits tumor growth
K Palmer, N Sharan, P Emtage, et al.
Oncogene
|
August 8, 2017
ErbB2-positive mammary tumors can escape PI3K-p110α loss through downregulation of the Pten tumor suppressor
A M Simond, T Rao, D Zuo, et al.
Molecular and Cellular Biology
|
March 10, 2001
Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression
J Hutchinson, J Jin, R D Cardiff, et al.
Nature Medicine
|
March 4, 2000
Suppression of tumor growth and metastasis in Mgat5-deficient mice
M Granovsky, J Fata, J Pawling, et al.
Genes & Development
|
January 1, 1994
Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice
C T Guy, S K Muthuswamy, R D Cardiff, et al.
Reproduction, Fertility, and Development
|
January 1, 1993
Production and secretion of progesterone in vitro and presence of platelet activating factor (PAF) in early pregnancy of the marsupial, Macropus eugenii
T Kojima, L A Hinds, W J Muller, et al.
International Journal of Cancer
|
July 3, 1997
Expression of transgenic carcinoembryonic antigen (CEA) in tumor-prone mice: an animal model for CEA-directed tumor immunotherapy
J A Thompson, A M Eades-Perner, M Ditter, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 115) with videos related to
Sort By:
Page
of 12
Oncogene
|
September 7, 1995
Telomerase activity in normal and malignant murine tissues
C Chadeneau, P Siegel, C B Harley, et al.
International Journal of Oncology
|
April 18, 1998
Tumour therapy in mice using adenovirus vectors expressing human TNFa
R A Marr, M Hitt, W J Muller, et al.
Molecular and Cellular Biology
|
September 1, 1997
Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation
D L Dankort, Z Wang, V Blackmore, et al.
Gene Therapy
|
June 25, 2002
Intratumoral administration of an adenovirus expressing a kinase dead form of ErbB-2 inhibits tumor growth
K Palmer, N Sharan, P Emtage, et al.
Oncogene
|
August 8, 2017
ErbB2-positive mammary tumors can escape PI3K-p110α loss through downregulation of the Pten tumor suppressor
A M Simond, T Rao, D Zuo, et al.
Molecular and Cellular Biology
|
March 10, 2001
Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression
J Hutchinson, J Jin, R D Cardiff, et al.
Nature Medicine
|
March 4, 2000
Suppression of tumor growth and metastasis in Mgat5-deficient mice
M Granovsky, J Fata, J Pawling, et al.
Genes & Development
|
January 1, 1994
Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice
C T Guy, S K Muthuswamy, R D Cardiff, et al.
Reproduction, Fertility, and Development
|
January 1, 1993
Production and secretion of progesterone in vitro and presence of platelet activating factor (PAF) in early pregnancy of the marsupial, Macropus eugenii
T Kojima, L A Hinds, W J Muller, et al.
International Journal of Cancer
|
July 3, 1997
Expression of transgenic carcinoembryonic antigen (CEA) in tumor-prone mice: an animal model for CEA-directed tumor immunotherapy
J A Thompson, A M Eades-Perner, M Ditter, et al.
Page
of 12